Tag:
Shanghai Schering-Plough Pharmaceutical
Latest Headlines
Latest Headlines
Shanghai looks to U.S., Europe for branded-drug buyout
Shanghai Pharmaceuticals is shopping. In the Chinese drugmaker and distributor's first strategic update as a public company, Shanghai said its near-term plans include two things: growth in branded
Shanghai Pharma IPO yields $2B
Shanghai Pharmaceuticals wrapped up its IPO in Hong Kong at a price of HK$23 per share, or almost $2 billion total. Pfizer was a key investor with $50 million in the deal. The stock will start
Shanghai, Sinopharm in jealous snit over investors
A spat between two Chinese drug companies--Sinopharm and Shanghai Pharmaceuticals--highlights how that country's state-run companies are increasingly competing as vigorously with one another as they
Pfizer, Shanghai expand Chinese collaboration
Pfizer ( $PFE ) has taken its relationship with China's Shanghai Pharmaceutical to a new level. Currently cooperating on Pfizer's Prevenar pneumococcal vaccine, the two companies plan to beef up those
Shanghai Pharma eyes $1.5B public offering
Shanghai Pharmaceuticals, Roche's Chinese partner and the second-largest drugmaker in that country, plans to raise $1.2 billion to $1.5 billion in a Hong Kong IPO in the second quarter of 2011,
